Analgesics in Serbia
The increased stress and anxiety of the Coronavirus (COVID-19) pandemic informed a spike in retail volume growth in analgesics in 2020 and 2021. Further strong retail volume growth is projected for 2022 as the economic and health climate remains uncertain, and consumers are in the habit to treating pain with analgesics. Adult acetaminophen and adult Ibuprofen are predicted to continue to see by far the fastest retail volume growth rates as consumers purchased these analgesics for pain and immuni...
Euromonitor International's Analgesics in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Analgesics in Serbia
- Euromonitor International
- September 2022
- List Of Contents And Tables
- ANALGESICS IN SERBIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Familiarity and trust continue to boost sales of acetaminophen and ibuprofen
- Difficulties in obtaining a doctor’s appointment and growing consumer knowledge encourage self-medication
- Advertising remains a key competitive tool
- PROSPECTS AND OPPORTUNITIES
- Self-medication and higher health awareness to sustain sales of analgesics
- Leading players expected to continue to use marketing and advertising to gain a competitive edge
- Expansion of chained drugstores/parapharmacies set to eat into pharmacies’ retail value share
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2017-2022
- Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
- Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
- Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN SERBIA
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Penetration of Private Label by Category: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook